Development and characterisation of chitosan nanoparticles for siRNA delivery.

[1]  C. Fong,et al.  Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Tao Wang,et al.  Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. , 2005, Colloids and surfaces. B, Biointerfaces.

[3]  Junfeng Zhang,et al.  Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  C. Cho,et al.  Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[5]  W. Ahn,et al.  The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. , 2005, Biomaterials.

[6]  Michael Keller,et al.  Lipidic carriers of RNA/DNA oligonucleotides and polynucleotides: what a difference a formulation makes! , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[7]  A. Zimmer,et al.  Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  B. Seijo,et al.  Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. , 2005, Journal of colloid and interface science.

[9]  A. Aigner,et al.  RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo , 2005, Gene Therapy.

[10]  Hiroyuki Miyoshi,et al.  Optimization of an siRNA‐expression system with an improved hairpin and its significant suppressive effects in mammalian cells , 2004, The journal of gene medicine.

[11]  Stephen P. Fox,et al.  Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes: In Vitro and In Vivo Studies , 2004, Journal of drug targeting.

[12]  Kazunori Kataoka,et al.  Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[13]  H. Junginger,et al.  PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium , 2004, European Journal of Pharmaceutics and Biopharmaceutics.

[14]  Raymond M. Schiffelers,et al.  Pharmaceutical Prospects for RNA Interference , 2004, Pharmaceutical Research.

[15]  D. Sørensen,et al.  Cationic liposome-mediated delivery of siRNAs in adult mice. , 2003, Biochemical and biophysical research communications.

[16]  David L. Lewis,et al.  siRNA delivery technologies for mammalian systems , 2003 .

[17]  A. Chan,et al.  Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. , 2003, Biochimica et biophysica acta.

[18]  Stephen P. Fox,et al.  Gene Silencing Nucleic Acids Designed by Scanning Arrays: Anti-EGFR Activity of siRNA, Ribozyme and DNA Enzymes Targeting a Single Hybridization-accessible Region using the Same Delivery System , 2003, Journal of drug targeting.

[19]  David R Corey,et al.  RNA interference in mammalian cells by chemically-modified RNA. , 2003, Biochemistry.

[20]  Mouldy Sioud,et al.  Gene silencing by systemic delivery of synthetic siRNAs in adult mice. , 2003, Journal of molecular biology.

[21]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[22]  K. Zhu,et al.  The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  K. Janes,et al.  Polysaccharide colloidal particles as delivery systems for macromolecules. , 2001, Advanced drug delivery reviews.

[24]  W. Zauner,et al.  In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[25]  O. Ludkovski,et al.  Stabilized plasmid-lipid particles for systemic gene therapy , 2000, Gene Therapy.

[26]  J. Nah,et al.  Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. , 2000, International journal of pharmaceutics.

[27]  C. Stein.  Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. , 1996, Trends in biotechnology.

[28]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[29]  V. Bloomfield,et al.  Condensation of DNA by multivalent cations: Considerations on mechanism , 1991, Biopolymers.

[30]  V. Bloomfield,et al.  Light scattering studies on DNA condensation. , 1991, Biochemical Society transactions.